Alcon Inc. (BVMF:A2LC34)

Market Cap	200.72B -23.2%
Revenue (ttm)	54.28B +4.3%
Net Income	5.58B -9.8%
EPS	11.19 -10.2%
Shares Out	n/a
PE Ratio	35.97
Forward PE	23.64
Dividend	0.12 (0.29%)
Ex-Dividend Date	May 13, 2025

Volume	1
Average Volume	5
Open	41.21
Previous Close	n/a
Day's Range	41.21 - 41.21
52-Week Range	39.20 - 55.60
Beta	n/a
RSI	40.38
Earnings Date	Feb 25, 2026

About Alcon

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. It operates through two segments, Surgical and Vision Care. The company offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. Its cataract products include Centurion vision system, LenSx laser system, Verion reference unit and Verion digital marker, ...

• Industry: Ophthalmic Goods
• Founded: 1945
• Employees: 25,000
• Stock Exchange: Brazil Stock Exchange
• Ticker Symbol: A2LC34

Financial Performance

In 2024, Alcon's revenue was $9.91 billion, an increase of 4.82% compared to the previous year's $9.46 billion. Earnings were $1.02 billion, an increase of 4.52%.

Financial numbers in USD